Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
View Older Stories View More Recent Stories
-
Auirga Trims Its Price Target On McKesson (MCK) to $75, Maintains Buy
-
Auriga Sees Plenty of Upside With Limited Downside For Micron (MU)
-
Auriga Reiterates a 'Buy' on First Solar (FSLR); Competitors Take Notice: First Solar Raised the Bar, Again
-
Auriga Maintains a 'Buy' on First Solar (FSLR); Increased Visibility into 2011
-
Auriga Ups Price Target on First Solar (FSLR) to $173
-
Will Sprint's (S) 4G Effort Take Hold in Q210?
-
Auriga Downgrades athenahealth (ATHN) to Hold
-
Auriga Raises Price Target On AT&T (T) to $26, Maintains Hold
-
Auriga On the Sidelines With Verizon (VZ) Into Results Friday
